期刊文献+

女性血液系统恶性肿瘤的生殖保护策略 被引量:2

The Fertility Preservation for Female with Hematologic Malignant Tumor
下载PDF
导出
摘要 血液系统恶性肿瘤是造血系统的恶性疾病,发病率在患恶性肿瘤的年轻人中居首位。化疗是其早期治疗的主要手段,但这会对女性的卵巢结构和功能产生严重的甚至是不可逆的损害。因此,对于患有血液系统恶性肿瘤的妇女,既要保护其卵巢的生殖功能,又不能影响其原发病的治疗效果。目前可能有效的生殖保护手段是胚胎冷冻、卵子冷冻、卵巢及卵巢组织冷冻、卵巢移位、促性腺激素释放激素(GnRH)类似物、避孕药和激素疗法等。 Blood system malignant tumor is a group of malignant diseases with the highest incidence in youth.For the early treatment,chemotherapy is of first choice.Chemotherapy will produce serious and irreversible damage for ovarian structure and function.So far the female with blood system malignant tumor,the primary chemotherapy should be carried with consideration of the fertility preservation of ovary.At present,the possible methods of effective fertility preservation are embryo cryopreservation,mature and immature oocyte cryopreservation,ovarian and ovarian tissue cryopreservation,ovarian transplantation,GnRH-analogues usage,oral contraceptive,hormone replacement therapy and so on.
作者 王磊 邵小光
出处 《国际生殖健康/计划生育杂志》 CAS 2012年第5期408-412,共5页 Journal of International Reproductive Health/Family Planning
关键词 血液肿瘤 抗肿瘤联合化疗方案 低温保存 促性腺素释放激素 治疗 Hematologic neoplasms; Antineoplastic combined chemotherapy protocols; Cryopreservation; Gonadotropin-releasing hormone; Therapy
  • 相关文献

参考文献24

  • 1Blumenfeld Z. How to preserve fertility in young woman exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embryo,oocytes,or ovaries [J]. Oncologist, 2007,12 ( 9 ) : 1044-1054.
  • 2Blumenfeld Z. Gender difference:fertility preservation in young women but not in men exposed to gonadotonix chemotherapy [J]. Minerva Endocrinol, 2007,32( 1 ) :23-34.
  • 3井甜甜,何援利.促性腺激素释放激素激动剂对大鼠化疗损伤卵巢功能的保护作用[J].中国妇幼保健,2008,23(16):2276-2279. 被引量:6
  • 4林琼燕,王沂峰,翁慧男,黄菊,江庆萍,吴秋华,陈高文.促性腺激素释放激素激动剂对卵巢上皮性癌裸鼠移植瘤化疗效果的影响及卵巢功能的保护作用[J].中华妇产科杂志,2010,45(6):460-462. 被引量:4
  • 5Blumenfeld Z ,von Wolff M. GnRH-analogues and oral contracep- tives for fertility preservation in women during chemotherapy [J]. Hum Reprod Update,2008,14(6):543-552.
  • 6Waxman JH, Ahmed R, Smith D, et al. Failure to preserve fertility in patients with Hodgkin's disease [J]. Cancer Chemother Pharma- col, 1987,19(2) : 159-162.
  • 7Blumenfeld Z,Shapiro D,Shteinberg M,et al. Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy [J]. Lupus ,2000,9(6) :401-405.
  • 8Pereyra Pacheco B,M6ndez Ribas JM,Milone G,et al. Use of GnRH analogs for functional protection of the ovary and preservation of fertility during cancer treatment in adolescents: a preliminary report [J]. Gynecol Oncol, 2001,81 ( 3 ) : 391-397.
  • 9Dann EJ,Epelbaum R,Avivi I,et al. Fertility and ovarian func- tion are preserved in women treated with an intensified regimen of cyclophosphamide,adriamycin ,vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphoma [J]. Hum Reprod,2005, 20 ( 8 ) : 2247-2249.
  • 10Somers EC,Marder W,Christman GM,et al. Use of a gonadotropin- releasing hormone analog for protection against premature ovarian failture during cyclophosphamide therapy in women with severe lupus [J]. Arthritis Rheum,2005,52(9):2761-2767.

二级参考文献10

  • 1袁光文,沈铿,杨佳欣.促性腺激素释放激素激动剂对卵巢癌大鼠化疗效果的影响[J].中华医学杂志,2005,85(20):1428-1431. 被引量:2
  • 2彭萍,杨冬梓,郑澄宇,赖宝玲,罗璐,刘惠芬,何钻玉.促性腺激素释放激素激动剂在化疗患者卵巢功能保护中应用的研究进展[J].中华妇产科杂志,2006,41(2):139-141. 被引量:15
  • 3Volker P,Grindker C,Schmidt O,et al.Expression of receptors for luteinizing hormone-releasing hormone in human ovarian and endometrial cancers:frequency,autoregulation,and correlation with direct antiproliferative activity of luteinizing hormone-releasing hormone analogues.Am J Obstet Gynecol,2002,186:171-179.
  • 4Danforth DR,Arbogast LK,Friedman CI.Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists.Fertil Steril,2005,83:1333-1338.
  • 5Myers M,Britt KL,Wreford NG,et al.Methods for quantifying follicular numbers within the mouse ovary.Reproduction,2004,127:569-580.
  • 6Perez GI,Maravei DV,Trbovich AM,et al.Identification of potassium-dependent and -independent componentsof the apoptotic machinery in mouse ovarian germ cells and granulosa cells.Biol Reprod,2000,63:1358-1369.
  • 7Janssens RM,Brus L,Cahill DJ,et al.Direct ovarian effects and safety aspects of GnRH agonists and antagonists.Hum Reprod Update,2000,6:505-518.
  • 8Blumenfeld Z,Eckman A.Preservation of fertility and ovarian function and minimization of chemotherapy-induced gonadotoxicity in young women by GnRH-a J Natl Cancer Inst Monogr,2005,34:40-43.
  • 9Zhu C,Luo J,Shi H,et al.Expression of tubulin,p53,ki67,receptors for estrogen,and progesterone in endometrial cancer.Eur J Gynaecol Oncol,2009,30:514-517.
  • 10艾浩,薛晓鸥,牛建昭,李健.顺铂腹腔注射对小鼠卵巢功能损伤机制的研究[J].中国妇产科临床杂志,2008,9(4):282-284. 被引量:7

共引文献8

同被引文献24

  • 1Domingo J, Guillen V, Ayllon Y,et al. Ovarian response to controlledovarian hyperstimulation in cancer patients is diminished evenbefore oncological treatment[J]. Fertil Steril, 2012, 97(4): 930-4.
  • 2Friedler S, Koc 0,Gidoni Y, et al. Ovarian response to stimulationfor fertility preservation in women with malignant disease: asystematic review and meta-analysis [j]. Fertil Steril, 2012, 97(1):125-33.
  • 3Ginsburg ES, Yanushpolsky EH, Jackson KV. In vitro fertilizationfor cancer patients and survivors [J]. Fertil Steril, 2001,75(4):705-10.
  • 4Thibaud E, Rodriguez-Macias K,Trivin C, et al. Ovarian functionafter bone marrow transplantation during childhood [J]. BoneMarrow Transplant, 1998, 21(3): 287-90.
  • 5Bulletin AP. 126: Management of gynecologic issues in womenwith breast cancer[J]. Obstet Gynecol, 2012, 119(3): 666-82.
  • 6Meirow D. Ovarian injury and modem options to preserve fertilityin female cancer patients treated with high dose radio-chemotherapy for hemato-oncological neoplasias and other cancers[J]. Leuk Lymphoma, 1999, 33(1/2): 65-76.
  • 7Meirow D, Biederman H, Anderson RA, et al. Toxicity ofchemotherapy and radiation on female reproduction[J].Clin ObstetGynecol, 2010, 53(4): 727-39.
  • 8Maltaris T, Seufert R, Fischl F, et al. The effect of cancer treatmenton female fertility and strategies for preserving fertility [J]. Eur JObstet Gynecol Reprod Biol, 2007, 130(2): 148-55.
  • 9Fasouliotis SJ, Davis 0,Schattman G, et al. Safety and efficacy ofinfertility treatment after conservative management of borderlineovarian tumors: a preliminary report [J]. Fertil Steril, 2004,82(3):568-72.
  • 10Wu HM, Lai CH, Huang HY,et al. A successful live twin birth byin vitro fertilization after conservative treatment of recurrentendometrial cancer[J]. Chang Gung Med J, 2008, 31(1): 102-6.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部